Evicenter
MarkdownMedical informationP&T meetings
Inaxaplin (VX-147)

APOL1-mediated kidney disease

Launch
Not announced
Last updated
162 sources

Product information and disease descriptionPlace of product in therapyDisease descriptionBurden of APOL1-mediated kidney disease

Economic burden and healthcare resource utilization

8 evidence topics · 7 sources

AMKD-specific health care resource utilization and cost studies

No evidence found.

Per person per year Medicare fee-for-service spending among older adults with CKD, by race and CKD stage